Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ware

Showing results (391-400 of 428) with videos related to

Pageof 43
Sort By:
Cancer|September 8, 2016
A multicenter, single-arm, open-label, phase 2 study of apitolisib (GDC-0980) for the treatment of recurrent or persistent endometrial carcinoma (MAGGIE study)Vicky Makker, Fernando O Recio, Ling Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2012
Bridging the gap between preclinical and clinical studies using pharmacokinetic-pharmacodynamic modeling: an analysis of GDC-0973, a MEK inhibitorHarvey Wong, Laurent Vernillet, Amy Peterson, et al.
Cancer Discovery|March 24, 2017
Phase I Dose-Escalation Study of Taselisib, an Oral PI3K Inhibitor, in Patients with Advanced Solid TumorsDejan Juric, Ian Krop, Ramesh K Ramanathan, et al.
Journal of the Endocrine Society|June 19, 2024
Diagnostic Accuracy of Transient Elastography in Hepatosteatosis in Youth With ObesityEmir Tas, Divya Sundararajan, Jaclyn S Lo, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Axially swept dithered light-sheet microscope to reveal cardiac morphologyMilad Almasian, Alireza Saberigarakani, Xinyuan Zhang, et al.
Clinical Pharmacology in Drug Development|August 27, 2022
Bioequivalence and Relative Bioavailability Studies to Assess a New Acalabrutinib Formulation That Enables Coadministration With Proton-Pump InhibitorsShringi Sharma, Xavier Pepin, Harini Burri, et al.
Psychoneuroendocrinology|July 9, 2023
Cellular allostatic load is linked to increased energy expenditure and accelerated biological agingNatalia Bobba-Alves, Gabriel Sturm, Jue Lin, et al.
Vaccine|August 15, 2006
Pre-clinical evaluation of new adjuvant formulations to improve the immunogenicity of the malaria vaccine RTS,S/AS02AV Ann Stewart, Shannon M McGrath, Douglas S Walsh, et al.
Journal of the American College of Cardiology|August 30, 2008
Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trialHarvey D White, E Magnus Ohman, A Michael Lincoff, et al.
Cannabis and Cannabinoid Research|October 4, 2019
Priority Considerations for Medicinal Cannabis-Related ResearchMarcel O Bonn-Miller, Charles V Pollack, David Casarett, et al.
Pageof 43

Showing results (391-400 of 428) with videos related to

Sort By:
Pageof 43
Cancer|September 8, 2016
A multicenter, single-arm, open-label, phase 2 study of apitolisib (GDC-0980) for the treatment of recurrent or persistent endometrial carcinoma (MAGGIE study)Vicky Makker, Fernando O Recio, Ling Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2012
Bridging the gap between preclinical and clinical studies using pharmacokinetic-pharmacodynamic modeling: an analysis of GDC-0973, a MEK inhibitorHarvey Wong, Laurent Vernillet, Amy Peterson, et al.
Cancer Discovery|March 24, 2017
Phase I Dose-Escalation Study of Taselisib, an Oral PI3K Inhibitor, in Patients with Advanced Solid TumorsDejan Juric, Ian Krop, Ramesh K Ramanathan, et al.
Journal of the Endocrine Society|June 19, 2024
Diagnostic Accuracy of Transient Elastography in Hepatosteatosis in Youth With ObesityEmir Tas, Divya Sundararajan, Jaclyn S Lo, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Axially swept dithered light-sheet microscope to reveal cardiac morphologyMilad Almasian, Alireza Saberigarakani, Xinyuan Zhang, et al.
Clinical Pharmacology in Drug Development|August 27, 2022
Bioequivalence and Relative Bioavailability Studies to Assess a New Acalabrutinib Formulation That Enables Coadministration With Proton-Pump InhibitorsShringi Sharma, Xavier Pepin, Harini Burri, et al.
Psychoneuroendocrinology|July 9, 2023
Cellular allostatic load is linked to increased energy expenditure and accelerated biological agingNatalia Bobba-Alves, Gabriel Sturm, Jue Lin, et al.
Vaccine|August 15, 2006
Pre-clinical evaluation of new adjuvant formulations to improve the immunogenicity of the malaria vaccine RTS,S/AS02AV Ann Stewart, Shannon M McGrath, Douglas S Walsh, et al.
Journal of the American College of Cardiology|August 30, 2008
Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trialHarvey D White, E Magnus Ohman, A Michael Lincoff, et al.
Cannabis and Cannabinoid Research|October 4, 2019
Priority Considerations for Medicinal Cannabis-Related ResearchMarcel O Bonn-Miller, Charles V Pollack, David Casarett, et al.
Pageof 43